LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291)
Hong Kong · Delayed Price · Currency is HKD 11.92
+0.21 (1.79%)
Jul 31, 2026, 4:08 PM HKT
HKG:2291 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 527.94 | 527.94 | 471.64 | 326.62 | 247.67 | 222.58 |
Revenue Growth | -4.40% | 11.94% | 44.40% | 31.88% | 11.27% | 50.14% |
Gross Profit Gross Profit Growth | 446.95 | 446.95 | 424.03 | 289.09 | 219.69 | 197.55 |
Operating Income Operating Income Growth | 256.81 | 256.81 | 255.56 | 152.88 | 105.97 | 95.75 |
Net Income Net Income Growth | 239.73 | 239.73 | 245.56 | 151.38 | -19.81 | 58.7 |
Earnings Per Share EPS Growth | 0.69 | 0.69 | 0.71 | 0.44 | -0.06 | 0.19 |
EPS Growth | -16.74% | -2.57% | 62.22% | - | - | -22.14% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Occluder Segment Occluder Segment Growth | 473.28 | 473.28 | 471.14 | 325.9 | 247.67 | 222.58 |
Heart Valve Segment Heart Valve Segment Growth | 54.2 | 54.2 | - | - | - | - |
Unallocated Other Operating Income Unallocated Other Operating Income Growth | 0.47 | 0.47 | 0.5 | 0.73 | - | - |
Total Total Growth | 527.94 | 527.94 | 471.64 | 326.62 | 247.67 | 222.58 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,178 | 1,178 | 1,233 | 1,267 | 1,203 | 713.48 |
Total Debt Total Debt Growth | 0.77 | 0.77 | 1.51 | 0.96 | 3.34 | 6.19 |
Net Cash (Debt) Net Cash Growth | 1,177 | 1,177 | 1,232 | 1,266 | 1,199 | 707.29 |
Net Cash Growth | -14.39% | -4.44% | -2.71% | 5.58% | 69.56% | 3554.88% |
Net Cash Per Share Net Cash Per Share Growth | 3.39 | 3.39 | 3.55 | 3.65 | 3.66 | 2.33 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 221.1 | 221.1 | 222.49 | 164.26 | 65.53 | 105.28 |
Capital Expenditures CapEx Growth | -76.44 | -76.44 | -85.44 | -97.51 | -13.28 | -22.45 |
Free Cash Flow Free Cash Flow Growth | 144.66 | 144.66 | 137.05 | 66.75 | 52.25 | 82.83 |
Free Cash Flow Growth | -24.26% | 5.55% | 105.32% | 27.75% | -36.92% | 46.41% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 84.66% | 84.66% | 89.91% | 88.51% | 88.70% | 88.75% |
Operating Margin | 48.64% | 48.64% | 54.19% | 46.81% | 42.79% | 43.02% |
Pretax Margin | 52.37% | 52.37% | 60.66% | 52.98% | -6.07% | 29.66% |
Profit Margin | 45.41% | 45.41% | 52.06% | 46.35% | -8.00% | 26.37% |
FCF Margin | 27.40% | 27.40% | 29.06% | 20.44% | 21.10% | 37.21% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.580 | 0.500 | 0.620 | 0.570 |
Dividend Per Share Growth | -15.01% | -19.36% | 8.77% | - |
Dividend Yield | 4.87% | 3.64% | 4.12% | 2.60% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.52 | 20.90 | 23.12 | 56.56 | - | - |
Forward PE | 7.13 | 11.88 | - | - | - | - |
P/FCF Ratio | 25.68 | 34.64 | 41.42 | 128.26 | 168.18 | - |
PS Ratio | 7.04 | 9.49 | 12.04 | 26.21 | 35.48 | - |